Provider
Erectile Dysfunction - Phosphodiesterase Type 5 Inhibitors, Topical Prostaglandin - Commercial
Quantity Limit
Program effective Date: Nov 01, 2025
Quantity Limit
Program effective Date: Nov 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Jun 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Aug 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Jun 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Jun 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Jun 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Aug 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Jun 01, 2025